Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy

  • Authors:
    • Yiqun Han
    • Peng Zhang
    • Yuanyuan Chen
    • Jiping Sun
    • Fansheng Kong
  • View Affiliations

  • Published online on: May 6, 2014     https://doi.org/10.3892/ijmm.2014.1770
  • Pages: 191-196
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The co-delivery of DNA and antitumor drugs has the potential to treat cancer. In this study, we aimed to develop surface-modified, co-encapsulated solid lipid nanoparticles (SLN) containing enhanced green fluorescence protein plasmid (pEGFP) and doxorubicin (DOX) in order to create a multifunctional delivery system that targets lung cancer cells, in an effort to improve the efficacy of cancer therapy. DOX- and pEGFP-loaded SLN were prepared separately and then mixed to form co-encapsulated SLN (SLN/DE). Transferrin (Tf)-containing ligands were used for the surface coating of the vectors. The in vitro transfection efficiency of the modified vectors was evaluated using a human alveolar adenocarcinoma cell line (A549 cells) and the in vivo transfection efficiency of the modified vectors was evaluated using mice bearing A549 tumors. The Tf-modified DOX and pEGFP co-encapsulated SLN (T-SLN/DE) had a particle size of 267 nm with a 42 mV surface charge. The in vitro cytotoxicity of T-SLN/DE was low (cell viability was between 80 and 100% compared with the controls). T-SLN/DE displayed a remarkable therapeutic effect both in drug delivery and gene therapy. In conclusion, our results demonstrate that the multifunctional delivery system can improve the efficacy of cancer therapy through the combination of gene therapy and chemotherapy. In addition, the coating of active targeting ligands can improve the efficacy of the carriers at targeting lung cancer cells. Thus, the novel gene and drug delivery system offers an effective strategy for lung cancer gene therapy.
View Figures
View References

Related Articles

Journal Cover

July 2014
Volume 34 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Han, Y., Zhang, P., Chen, Y., Sun, J., & Kong, F. (2014). Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy. International Journal of Molecular Medicine, 34, 191-196. https://doi.org/10.3892/ijmm.2014.1770
MLA
Han, Y., Zhang, P., Chen, Y., Sun, J., Kong, F."Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy". International Journal of Molecular Medicine 34.1 (2014): 191-196.
Chicago
Han, Y., Zhang, P., Chen, Y., Sun, J., Kong, F."Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy". International Journal of Molecular Medicine 34, no. 1 (2014): 191-196. https://doi.org/10.3892/ijmm.2014.1770